Now that the patent has expired, this cancer drug is suddenly 99% cheaper

The patent on the cancer drug Revlimid (lenalidomide) recently expired. Whereas a few weeks ago a pack still cost over 4,500 euros, after generic competition this is now only about 20 euros. This means that Dutch hospitals will save over 130 million euros. By Lucien Hordijk and Liza van Lonkhuyzen | 24 March 2022 Many …

Now that the patent has expired, this cancer drug is suddenly 99% cheaper Read More »